Risk of progression of pulmonary ground-glass nodules based on clinical combined imaging in Chinese medicine

Risk assessment model of pulmonary grinding glass nodule progression based on TCM clinical-imaging

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2024000002

Enrollment

Unknown

Registered

2024-01-07

Start date

2024-01-08

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Pulmonary Nodules

Interventions

Progress and Non-Progress:NA

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) GGN was diagnosed by two consecutive CT reports at an interval of more than 6 months; (2) Age: adults over 18 years old; (3) Clinical and imaging data were complete; (4) clear mind and normal understanding ability; (5) The patient has obtained informed consent.

Exclusion criteria

Exclusion criteria: (1) those with unknown changes in lung nodules; (2) those undergoing targeted therapy, chemotherapy, or immunotherapy; (3) those diagnosed with other (excluding lung) malignant tumors; (4) those who are confused and have poor comprehension ability; and (5) those incomplete clinical and imaging data.

Design outcomes

Primary

Measure	Time frame
History of surgery;TCM clinical symptom;Size of Lung nodule;History of other diseases;life style;History of drug allergy;gender;Family history of cancer;number of pulmonary nodule;The density of pulmonary nodule;age;upper lobe;Pollutant exposure history;educational level;History of exposure to cooking fumes;Malignant signs of pulmonary nodule;	—

Countries

China

Contacts

Public ContactHua Bao-Jin

Guang'anmen Hospital, China Academy of Chinese Medicine Sciences

huabaojinxs@126.com13601080418

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026